Search results
Author(s):
Julia Sikorska
,
James Uprichard
Added:
3 years ago
For more than 50 years, oral vitamin K antagonists (VKAs) were the choice of anticoagulant for the long-term treatment and prevention of arterial and venous thromboembolic events (VTE). VKA treatment is safe and effective, if a high time in therapeutic range is achieved. However, achieving a stable, therapeutic international normalised ratio can prove challenging in the context of drug and food…
View more
Author(s):
Mahmoud Abdelnabi
,
Abdallah Almaghraby
,
Yehia Saleh
Added:
3 years ago
Vitamin K antagonist (VKA) oral anticoagulants have been ruling the field of anticoagulation for cardiovascular indications for years now. Recently, this dominance has been threatened by the introduction of direct oral anticoagulants (DOACs), with abundant data highlighting their safety and efficacy. To date, recent guidelines have limited the use of DOACs to stroke prevention in patients with…
View more
Author(s):
Han Naung Tun
,
May Thu Kyaw
,
Erik Rafflenbeul
,
et al
Added:
1 year ago
Author(s):
Antoni Martínez-Rubio
,
Mario DiazNuila-Alcazar
,
Anna Soria Cadena
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most commonly encountered arrhythmia in clinical practice in Western countries. The prevalence of AF depends on the population studied1 and especially on age.2–9 It is affected by increasing longevity and is modulated by the prevalence of cardiovascular risk factors, especially arterial hypertension and related habits. In Spain, for example, the prevalence of AF…
View more
Direct Oral Anticoagulants Concentration Testing in Clinical Practice for High-Risk Patients with AF
Author(s):
K Pukite
,
I Urtane
,
I Pupkevica
,
et al
Added:
3 years ago
Article
Author(s):
Fernando Worner
,
Cristina Marzo
,
Kristian Rivera
,
et al
Added:
3 years ago
Topic: 1. Clinical Cardiology
Introduction
Universal use of Directs Oral Anticoagulants (DOACs) in non valvular atrial fibrillation (nVAF) is not possible for economic reasons. Therefore, it is mandatory to guarantee their prescription of these drugs in patients theoretically most benefited.
Objectives
To review indications and results of one territorial, prospective and centralized…
View more
Author(s):
Daniel TT Chong
,
Felicita Andreotti
,
Peter Verhamme
,
et al
Added:
2 years ago
Joan Antoni Schoenenberger
Research Area(s) / Expertise:
Author
Felicita Andreotti
Research Area(s) / Expertise:
Job title: Professor of Cardiovascular Medicine
Author